PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
AMGN vs. GILD
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


AMGNGILD
YTD Return17.81%-3.42%
1Y Return46.57%3.29%
3Y Return (Ann)14.55%8.06%
5Y Return (Ann)17.32%7.03%
10Y Return (Ann)13.70%1.42%
Sharpe Ratio1.890.13
Daily Std Dev24.63%24.24%
Max Drawdown-78.04%-70.84%
Current Drawdown-0.50%-14.19%

Fundamentals


AMGNGILD
Market Cap$178.76B$88.67B
EPS$7.00$0.36
PE Ratio47.61197.69
PEG Ratio2.390.42
Total Revenue (TTM)$22.50B$20.85B
Gross Profit (TTM)$14.38B$16.17B
EBITDA (TTM)$8.10B$8.77B

Correlation

-0.50.00.51.00.4

The correlation between AMGN and GILD is 0.39, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

AMGN vs. GILD - Performance Comparison

In the year-to-date period, AMGN achieves a 17.81% return, which is significantly higher than GILD's -3.42% return. Over the past 10 years, AMGN has outperformed GILD with an annualized return of 13.70%, while GILD has yielded a comparatively lower 1.42% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


4,000.00%6,000.00%8,000.00%10,000.00%12,000.00%14,000.00%16,000.00%FebruaryMarchAprilMayJuneJuly
5,176.87%
16,532.61%
AMGN
GILD

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Amgen Inc.

Gilead Sciences, Inc.

Risk-Adjusted Performance

AMGN vs. GILD - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Amgen Inc. (AMGN) and Gilead Sciences, Inc. (GILD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


AMGN
Sharpe ratio
The chart of Sharpe ratio for AMGN, currently valued at 1.89, compared to the broader market-2.00-1.000.001.002.003.001.89
Sortino ratio
The chart of Sortino ratio for AMGN, currently valued at 2.94, compared to the broader market-4.00-2.000.002.004.002.94
Omega ratio
The chart of Omega ratio for AMGN, currently valued at 1.37, compared to the broader market0.501.001.502.001.37
Calmar ratio
The chart of Calmar ratio for AMGN, currently valued at 2.42, compared to the broader market0.001.002.003.004.005.002.42
Martin ratio
The chart of Martin ratio for AMGN, currently valued at 6.09, compared to the broader market-30.00-20.00-10.000.0010.0020.006.09
GILD
Sharpe ratio
The chart of Sharpe ratio for GILD, currently valued at 0.13, compared to the broader market-2.00-1.000.001.002.003.000.13
Sortino ratio
The chart of Sortino ratio for GILD, currently valued at 0.36, compared to the broader market-4.00-2.000.002.004.000.36
Omega ratio
The chart of Omega ratio for GILD, currently valued at 1.05, compared to the broader market0.501.001.502.001.05
Calmar ratio
The chart of Calmar ratio for GILD, currently valued at 0.11, compared to the broader market0.001.002.003.004.005.000.11
Martin ratio
The chart of Martin ratio for GILD, currently valued at 0.23, compared to the broader market-30.00-20.00-10.000.0010.0020.000.23

AMGN vs. GILD - Sharpe Ratio Comparison

The current AMGN Sharpe Ratio is 1.89, which is higher than the GILD Sharpe Ratio of 0.13. The chart below compares the 12-month rolling Sharpe Ratio of AMGN and GILD.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.001.502.002.50FebruaryMarchAprilMayJuneJuly
1.89
0.13
AMGN
GILD

Dividends

AMGN vs. GILD - Dividend Comparison

AMGN's dividend yield for the trailing twelve months is around 2.62%, less than GILD's 3.97% yield.


TTM20232022202120202019201820172016201520142013
AMGN
Amgen Inc.
2.62%2.96%2.95%3.13%2.78%2.41%2.71%2.65%2.74%1.95%1.53%1.65%
GILD
Gilead Sciences, Inc.
3.97%3.70%3.40%3.91%4.67%3.88%3.65%2.90%2.57%1.27%0.00%0.00%

Drawdowns

AMGN vs. GILD - Drawdown Comparison

The maximum AMGN drawdown since its inception was -78.04%, which is greater than GILD's maximum drawdown of -70.84%. Use the drawdown chart below to compare losses from any high point for AMGN and GILD. For additional features, visit the drawdowns tool.


-30.00%-25.00%-20.00%-15.00%-10.00%-5.00%0.00%FebruaryMarchAprilMayJuneJuly
-0.50%
-14.19%
AMGN
GILD

Volatility

AMGN vs. GILD - Volatility Comparison

The current volatility for Amgen Inc. (AMGN) is 4.62%, while Gilead Sciences, Inc. (GILD) has a volatility of 7.26%. This indicates that AMGN experiences smaller price fluctuations and is considered to be less risky than GILD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


4.00%6.00%8.00%10.00%12.00%14.00%FebruaryMarchAprilMayJuneJuly
4.62%
7.26%
AMGN
GILD

Financials

AMGN vs. GILD - Financials Comparison

This section allows you to compare key financial metrics between Amgen Inc. and Gilead Sciences, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items